Cardioxyl Pharmaceuticals Raises $28 Million In Series B Financing Led By ...

13-11-2012 Sacramento BeeComments (0)


CHAPEL HILL, N.C., Nov. 13, 2012 -- /PRNewswire/ -- Cardioxyl Pharmaceuticals, Inc. announced today that it has raised $28 million in a Series B financing led by OrbiMed Advisors. New investor Osage University Partners joined OrbiMed and returning ...

Read more on Sacramento Bee

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top